Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for treating inflammatory bowel disease

A technology for formulating prescriptions for inflammatory bowel disease, which is applied in the field of combined formulas of Chinese herbal medicines and amino acids, can solve problems such as unsatisfactory effects and large side effects, and achieve the effects of prolonging human life, good therapeutic effects, and enhancing blood supply

Inactive Publication Date: 2016-03-23
何松庆
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] 1. Make chewing agent with 0.5 grams of Ganoderma lucidum, 0.6 grams of Salvia miltiorrhiza, 1.2 grams of glutamine, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cysteine, 2 to 4 times a day.

[0026] 2. Make chewing agent with 0.25 grams of Ganoderma lucidum, 0.3 grams of Salvia miltiorrhiza, 0.6 grams of glutamine, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cysteine, 2 to 4 times a day.

[0027] 3. 0.5 grams of ganoderma lucidum, 0.6 grams of salvia miltiorrhiza, 1.2 grams of glutamine, 0.5 grams of threonine, 0.6 grams of serine, and 0.06 grams of cysteine ​​are made into medicines, 2 to 4 times a day.

[0028] 4. 0.25 grams of Ganoderma lucidum, 0.3 grams of Salvia miltiorrhiza, 0.6 grams of glutamine, 0.25 grams of threonine, 0.3 grams of serine, and 0.03 grams of cysteine ​​are made into medicines, 2 to 4 times a day.

[0029] 5. 5 grams of ganoderma lucidum, 6 grams of salvia miltiorrhiza, 1.2 grams of glutamine, 0.5 grams o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for treating inflammatory bowel disease, and belongs to the field of drugs. The composition follows principles of reinforcing intestinal epithelial goblet cells, building a normal intestinal surface mucous layer barrier, preventing an antigen approaching, touching, adhering to and entering an intestinal wall, and then blocking an abnormal immune response and the occurrence of inflammation. In the composition, ganoderma and radix salviae miltiorrhizae have efficacies of strengthening blood supply and oxygen supply to the human body; glutamine is a main energy source of intestinal mucosa; threonine, serine and cysteine are components of mucoprotein. The composition provides nutrition, oxygen and raw materials for generation, renewal and repairing of the goblet cells as well as forming of an intestinal surface mucous layer barrier by utilizing mucoprotein secreted by the goblet cells, has obvious effects of building the normal intestinal surface mucous layer barrier for the human body, eliminating inflammation and repairing intestinal tissues, and is used for effectively treating the inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immune system and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/537A61P1/00A61P1/12A61P11/02A61P11/06A61P37/08A61K36/074A61K31/198
CPCA61K31/198A61K36/074A61K36/537A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com